Telomeres and telomerase in ageing and cancer

Age

Volumn 22, Issue 2, 1999, Pages 59-64

  Cowell, John K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

APOPTOSIS; ARTICLE; CANCER; CELL AGING; CELL IMMORTALIZATION; ENZYME INACTIVATION; GENE EXPRESSION; HUMAN; NONHUMAN; PROTEIN TARGETING; TELOMERE;

EID: 0032822975     PISSN: 01619152     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11357-999-0007-2     Document Type: Article

References (44)

1. Blackburn, EH: The molecular structure of centromeres and telomeres. Ann. Rev. Biochem., 53: 163-194, 1984.
2. Zakian, VA: Telomeres: beginning to understand the end. Science, 270: 1601-1607, 1995.
3. Moyzis, RK, Buckingham, JM, Cram, LS, Dani, M, Deaven, LL, Jones, MD, Meyne, J, Ratliff, RL, and Wu, JR: A highly conserved repetitive DNA sequence (TTAGGG)n, present at the telomeres of human chromosomes. Proc. Natl. Acad. Sci., 83: 6622-6626, 1988.
4. Greider, CW: Telomere length regulation. Ann. Rev. Biochem., 65: 337-365, 1996.
5. Hastie, ND, Dempster, M, Dunlop, MG, Thompson, AM, Green, DK, and Allshire, RC: Telomere reduction in human colorectal carcinoma and with ageing. Nature, 346: 866-868, 1990.
6. Hayflick, L, and Moorhead, PS: The serial cultivation of human diploid cell strains. Exp. Cell. Res., 25: 585-621, 1961.
7. Shay, JW, Pereira-Smith, OM, and Wright WE: A role for both RB and p53 in the regulation of human senescence. Exp. Cel Res., 196: 33-39, 1991.
8. Counter, CM, Avilion, AA, LeFeuvre, CE, Stewart, NG, Greider, CW, Harley, CB, and Bacchetti, S: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J., 11: 1921-1929, 1992.
9. Sack, GH: Human cell transformation by simian virus 40 - a review. In Vitro, 17: 1-19, 1981.
10. Counter, CM, Meyerson, M, Eaton, EN, and Weinberg, RA: The catalytic subunit of yeast telomerase. Proc. Natl. Acad. Sci. USA, 94: 9202-9207, 1997.
11. McEachern, MJ, and Blackburn EH: Runaway telomere elongation caused by telomerase RNA gene mutations. Nature, 376: 403-409, 1995.
12. Broccoli, D, Young, JW, and deLange, T: Telomerase activity in normal and malignant hematopoietic cells. Proc. Natl. Acad. Sci, USA, 92: 9082-9086, 1995.
13. Hsiao, R, Sharma, HW, Ramakrishnan, S, Keith, E, and Narayanan, R: Telomerase activity in normal human endothelial cells. Anticancer Res., 17: 827-832, 1997.
14. Harle-Bachor, C, and Boukamp, P: Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc. Natl. Acad. Sci. USA, 93: 6476-6481, 1996.
15. Belair, CD, Yeager, TR, Lopez, PM, and Reznikoff, CA: Telomerase activity: A biomarker of cell proliferation, not malignant transformation. Proc. Natl. Acad. Sci. USA, 94: 13677-13682, 1997.
16. Landberg, G, Nielsen, NH, Nilsson, P, Emdin, SO, Cajander, J, and Roos, G: Telomerase activity is associated with cell cycle deregulation in human breast cancer. Cancer Res., 57: 549-554, 1997.
17. Martens UM, Zijlmans JM, Poon SS, Dragowska W, Yui J, Chavez EA, Ward RK, and Lansdorp PM: Short telomeres on human chromosome 17p. Nature Genet., 18: 76-80, 1998.
18. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW and Villeponteau B: The RNA component of human telomerase. Science, 269: 1236-1241, 1995.
19. Harrington, L, McPhail, T, Mar V. Zhou, W, Oulton, R, Program, AE, Bass, MB, Arruda I, and Robinson, MO: A mammalian telomerase-associated protein. Science, 275: 973-977, 1997.
20. Nakayama, J-I, Saito, M, Nakamura, H, Matsuura, A, and Ishikawa, F: TLP: A gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell, 88: 875-884, 1997.
21. Meyerson, M, Counter, CM, Eaton, ENg, Ellisen, LW, Steiner, P, Dickinson Caddie, S, Ziaugra, L, Beijersbergen, RL, Davidoff, MJ, Qingyun, L, Bacchetti, S, Haber, DA, and Weinberg, RA: hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell, 90: 785-795, 1997.
22. Kilian, A, Bowtell DDL, Abud, HE, Hime, GR, Venter, DJ, Keese, PK, Duncan, EL, Reddel, RR, and Jefferson, RA: Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum. Molec. Genet., 6: 2011-2019, 1997.
23. Bodnar, AG, Ouellette, M, Frolkis, M, Holt, SE, Chiu, CP, Morin, GB, Harley CB, Shay, JW, Lichtsteiner, S, and Wright, WE: Extension of life-span by introduction of telomerase into normal human cells. Science, 279: 349-352, 1998.
24. Harley, CB, Kim, NW, Prowse, KR, Weinrich, SL, Hirsch, KS, West, MD, Bacchetti, S, Hirte, HW, Counter, CM, and Greider, CW: Telomerase, cell immortality, and cancer. Cold Spring Harb. Symp. Quant. Biol., 59: 307-315, 1994.
25. Kim, NW, Piatyszek, MA, Prowse, KR, Harley, CB, West, MD, Ho, PL, Coviello, GM, Wright, WE, Weinrich, SL, and Shay, JW: Specific association of human telomerase activity with immortal cells and cancer. Science, 266: 2011-2015, 1994.
26. Shay, JW, and Bacchetti, S: A survey of telomerase activity in human cancer. Eur. J. Cancer, 33: 787-791, 1997.
27. Kondo S, Tanaka Y, Kondo Y, Hitomi M, Barnett GH, Ishzaka Y, Liu J, Haqqi T, Nishiyama A, Villeponteau B, Cowell JK, Barna BP: (1998) Antisense telomerase treatment: Induction of two distinct pathways, Apoptosis and Differentiation. FASEB. J. 12, 801-811.
28. Hiyama, E, Hiyama, K, Yokohama, T, Mmitsuura, Y, Piatysek, MA and Shay, JW: Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Medicine. 1: 249-255, 1995.
29. Bryan, TM, Englezou, A, Dalla-Pozza, L, Dunham, MA, Redell, RR: Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nature Medi-cine, 3: 1271-1274, 1997.
30. Avilion, AA, Piatyszek, MA, Gupta, J., Shay, JW, Bacchetti, S, and Greider, CW: Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res., 56: 645-650, 1996.
31. Blasco, MA, Lee, H-W, Hande, MP, Samper, E, Lansdorp, PM, DePinho, RA, and Greider, CW: Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA, Cell, 91: 25-34, 1997.
32. Harley, CB, and Sherwood SW: Telomerase, checkpoints and cancer. Cancer Surveys, 29: 263-284, 1997.
33. Lee, H-W, Blasco, MA, Gottlieb, GJ, Horner, JW, Greider, CW, and DePinho, RA: Essential role of mouse telomerase in highly proliferative organs. Nature, Vol. 392: 569-574, 1998.
34. Kondo S, Tanaka Y, Kondo Y, Hitomi M, Barnett GH, Ishizaka Y, Liu J, Haqqi T, Nishiyama A, Villeponteau B, Cowell JK and Barna BP: Antisense telomerase treatment; induction of two distinct pathways, apoptosis and differentiation. FEBSJ.
35. Silverman RH. 2-5A dependent RNase L: A regulated endoribonuclease in the interferon system. In, "Ribonuclease: structure and function", (eds. G. D'Alessio and J.F. Riordan), Academic Press, Inc., 1997.
36. Kerr IM and Brown RE: pppA2′p5′A2′p5′A: An inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc. Natl. Acad. Sci. USA, 75: 256-260, 1978.
37. Johnston MI and Torrence PF. In; Interferon vol. 3 (ed. Friedman RM) pp. 189-298, Elsevier Science, New York, 1984.
38. Clemens MJ and Williams BRG: Inhibition of cell-free protein synthesis by pppA2′p5′A2′p5′A: A novel oligonucleotide synthesized by interferon-treated cell extracts. Cell, 13: 565-572, 1978.
39. Zhou A, Hassel BA and Silverman RH: Expression cloning of 2-5A-dependent RNAase; a uniquely regulated mediator of interferon action. Cell, 72: 753-765, 1993.
40. Torrence, PF., Maitra, RK., Lesiak, K., Khamnei, S., Zhou, A., and Silverman, RH: Targeting RNA for degradation with a (2′-5′) oligoadenylate-antisense chimera. Proc. Natl. Acad. Sci. USA, 90: 1300-1304, 1993.
41. Maran, A., Maitra, RK., Kumar, A., Dong, B., Xiao, W., Li, G., Williams, BRG., Torrence, PF., and Silverman, RH: Blockage of NF-κB signaling by selective ablation of an mRNA target by 2-5A antisense chimeras. Science, 265: 789-792, 1994.
42. Hassel, BA., Zhou, A., Sotomayor, C., Maran, A., and Silverman, RH: A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J., 12: 3297-3304, 1993.
43. Maitra, RK., Li, G., Xiao, W., Dong, B., Torrence, PF., and Silverman, RH: Catalytic cleavage of an RNA target by 2-5A antisense and RNase L. J. Biol. Chem., 270: 15071-15075, 1995.
44. Cirino, NM., Li, G., Xiao, W., Torrence, PF., and Silverman, RH: Targeting RNA decay in respiratory syncytial virus infected cells with 2′->5′ oligoadenylate-antisense. Proc. Natl. Acad. Sci. USA, 94: 1937-1942, 1997.